Skip to content

PRP in infertility

Evaluation of the effect of PRP on the outcome of IVF cycle in poorly responding patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220809055651N1
Enrollment
15
Registered
2022-10-30
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of the effect of PRP on the outcome of IVF cycle in poorly responding patients.

Interventions

The present study is a before and after clinical trial study that will be conducted in Shahid Beheshti Hospital, Kashan. This study will be conducted on 15 poor responder patients of group 3 and 1 pos

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 35 Years

Inclusion criteria

Inclusion criteria: This study will be conducted on 15 poor responder patients of group 3 and 1 poseidon. Inclusion criteria: age less than 35 years, BMI less than 30 and AMH1.2 ng/ml AFC >5 (Group 1 of Poseidon).

Exclusion criteria

Exclusion criteria: Hematological disorders (leukemia, thrombocytopenia), immunological disorders (antiphospholipid syndrome, thrombophilia), hormonal disorders (diabetes, thyroid, hyperprolactinemia), chromosomal and genetic abnormalities (hereditary or congenital) and kidney failure.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Ultrasound.;Oocyte count. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Ultrasound (sonography).

Secondary

MeasureTime frame
ANTI MOULLERIAN HORMON. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Measurement by blood test analysis after eight hours of fasting and without intimacy and stress the night before.;Follicle-stimulating Hormone. Timepoint: Before entering the cycle on the fifth day of the eighth and three months later. Method of measurement: Measurement by blood test analysis after eight hours of fasting and without intimacy and stress the night before.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra usefi

Kashan University of Medical Sciences

usefi-z@kaums.ac.ir+98 31 3650 8827

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026